title: FDA under pressure to relax drug rules.
authors.forename: Heidi
authors.initials: H
authors.lastname: Ledford
mesh_terms: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002423:Cause of Death; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence* / Q000379:methods* / Q000706:statistics & numerical data; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D048628:Ketolides / Q000009:adverse effects; D000077427:Lipoglycopeptides; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D048628:Ketolides; D000077427:Lipoglycopeptides; C106791:telithromycin; C487637:telavancin